Publications

Detailed Information

Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study

DC Field Value Language
dc.contributor.authorLee, S. -H.-
dc.contributor.authorKim, B. J.-
dc.contributor.authorBae, H. -J.-
dc.contributor.authorLee, J. S.-
dc.contributor.authorPark, B. -J.-
dc.contributor.authorYoon, B. -W.-
dc.contributor.authorLee, J.-
dc.date.accessioned2012-06-07T08:21:41Z-
dc.date.available2012-06-07T08:21:41Z-
dc.date.issued2010-03-
dc.identifier.citationDIABETOLOGIA; Vol.53 3; 429-434ko_KR
dc.identifier.issn0012-186X-
dc.identifier.urihttps://hdl.handle.net/10371/76882-
dc.description.abstractAdmission hyperglycaemia is associated with a poor outcome in patients with ischaemic stroke. However, its prognostic effects after intracerebral haemorrhage (ICH) are still unclear. We prospectively enrolled patients with ICH at 33 centres in Korea between October 2002 and March 2004. A total of 1,387 patients who had ICH and underwent brain computed tomography within 48 h of symptom onset were included in the study (n = 1,387). Clinical information and radiological findings were collected at admission. Glucose levels were examined in relation to early (up to 30 days after ictus) and long-term (after 30 days) mortality rates using Cox regression analysis. To eliminate short-term effects, long-term mortality rate analysis was performed on surviving patients for more than 30 days. The long-term mortality rate was 21.1% after a mean follow-up of 434.3 +/- 223.2 days and was found to increase significantly with glucose quartile (p < 0.001). Admission glucose level was an independent risk factor for early mortality (per mmol/l; adjusted HR 1.10 [95% CI 1.01-1.19]), but not for long-term mortality. Moreover, when analysis was restricted to patients without diabetes, glucose level was found to be an independent risk factor for post-ICH mortality (n = 1,119; adjusted HR 1.10 [95% CI 1.03-1.17]) and had marginal significance for early (p = 0.053) and long-term mortality (p = 0.09). We found that admission glucose levels were associated with early mortality after ICH. In patients without diabetes, admission glucose levels were associated with long-term mortality. We therefore suggest that intensive lowering of glucose level should be further investigated in ICH patients.ko_KR
dc.language.isoenko_KR
dc.publisherSPRINGERko_KR
dc.subjectGlucoseko_KR
dc.subjectMortalityko_KR
dc.subjectIntracerebral haemorrhageko_KR
dc.titleEffects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Studyko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1007/s00125-009-1617-z-
dc.citation.journaltitleDIABETOLOGIA-
dc.description.citedreferenceGodoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1-
dc.description.citedreferenceHuang BR, 2008, INTERN MED J, V38, P568, DOI 10.1111/j.1445-5994.2007.01536.x-
dc.description.citedreferenceGray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7-
dc.description.citedreferenceYoon BW, 2007, NEUROLOGY, V68, P146, DOI 10.1212/01.wnl.0000250351.38999.f2-
dc.description.citedreferenceFogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819-
dc.description.citedreferencePassero S, 2003, NEUROLOGY, V61, P1351-
dc.description.citedreferenceSong EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C-
dc.description.citedreferenceCheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9-
dc.description.citedreferenceMegherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40-
dc.description.citedreferenceSlowik A, 2002, J NEUROL SCI, V196, P27-
dc.description.citedreferenceVan den Berghe G, 2001, NEW ENGL J MED, V345, P1359-
dc.description.citedreferenceCapes SE, 2001, STROKE, V32, P2426-
dc.description.citedreferenceHemphill JC, 2001, STROKE, V32, P891-
dc.description.citedreferenceArboix A, 2000, DIABETES CARE, V23, P1527-
dc.description.citedreferenceGabir MM, 2000, DIABETES CARE, V23, P1108-
dc.description.citedreferenceGong C, 2000, BRAIN RES, V871, P57-
dc.description.citedreferenceWeir CJ, 1997, BRIT MED J, V314, P1303-
dc.description.citedreferenceMASE G, 1995, ACTA NEUROL SCAND, V91, P306-
dc.description.citedreferenceVANKOOTEN F, 1993, STROKE, V24, P1129-
dc.description.citedreferenceFRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653-
dc.description.citedreferenceARAKI N, 1992, J CEREBR BLOOD F MET, V12, P469-
dc.description.citedreferenceTUHRIM S, 1991, ANN NEUROL, V29, P658-
dc.description.citedreferenceOPPENHEIMER SM, 1985, BRIT MED J, V291, P1014-
dc.description.citedreferenceCHAN PH, 1984, NEUROLOGY, V34, P315-
dc.description.citedreferenceMELAMED E, 1976, J NEUROL SCI, V29, P267-
dc.description.tc10-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share